Literature DB >> 10511863

Factors associated with prognosis for survival and athletic use in foals with septic arthritis: 93 cases (1987-1994).

C M Steel1, A R Hunt, P L Adams, I D Robertson, C Chicken, J V Yovich, J A Stick.   

Abstract

OBJECTIVE: To identify factors affecting the prognosis for survival and athletic use in foals with septic arthritis.
DESIGN: Retrospective study. ANIMALS: 93 foals with septic arthritis. PROCEDURE: Medical records were reviewed to obtain clinical findings, laboratory test results, radiographic findings, treatment method, and outcome. Race records for Thoroughbreds and Standardbreds were evaluated to determine whether foals subsequently raced and whether they raced successfully.
RESULTS: 43 foals had 1 affected joint, 44 foals had multiple affected joints, and number of affected joints was not recorded for 6 foals. The femoropatellar and tarsocrural joints were most commonly affected. Osteomyelitis or degenerative joint disease were detected in 59% (46/78) of foals. Failure of passive transfer, pneumonia, and enteritis were common. Foals were treated with lavage, lavage and intra-articular administration of antibiotics, lavage and arthroscopic debridement with or without partial synovectomy, or lavage and arthrotomy to debride infected bone and systemic administration of antibiotics. Seventy-three foals survived to be discharged from hospital, and approximately a third raced. Isolation of Salmonella spp from synovial fluid was associated with an unfavorable prognosis for survival and multisystem disease was associated with an unfavorable prognosis for survival and ability to race; other variables were not significantly associated with survival and ability to race. CONCLUSIONS AND CLINICAL RELEVANCE: With treatment, the prognosis for survival of foals with septic arthritis was favorable, whereas prognosis for ability to race was unfavorable. Multisystem disease, isolation of Salmonella spp from synovial fluid, involvement of multiple joints, and synovial fluid neutrophil count > or = 95% at admission may be of prognostic value.

Entities:  

Mesh:

Year:  1999        PMID: 10511863

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  7 in total

1.  Prognostic factors in the sick neonatal foal.

Authors:  C Castagnetti; M C Veronesi
Journal:  Vet Res Commun       Date:  2008-09       Impact factor: 2.459

2.  Use of serum amyloid A in serum and synovial fluid to detect eradication of infection in experimental septic arthritis in horses.

Authors:  Seiji Yoshimura; Roman V Koziy; Ryan Dickinson; Igor Moshynskyy; Joscelyn A McKenzie; Elemir Simko; José L Bracamonte
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

3.  Analysis of factors influencing prognosis in foals with septic arthritis.

Authors:  Nicolas J Vos; Norm G Ducharme
Journal:  Ir Vet J       Date:  2008-02-01       Impact factor: 2.146

4.  Development of a likelihood of survival scoring system for hospitalized equine neonates using generalized boosted regression modeling.

Authors:  Katarzyna A Dembek; Samuel D Hurcombe; Michele L Frazer; Peter R Morresey; Ramiro E Toribio
Journal:  PLoS One       Date:  2014-10-08       Impact factor: 3.240

5.  Factors Associated With Survival and Return to Function Following Synovial Infections in Horses.

Authors:  Danielle E Crosby; Raphael Labens; Kristopher J Hughes; Sharon Nielsen; Bryan J Hilbert
Journal:  Front Vet Sci       Date:  2019-10-22

Review 6.  A review of equine sepsis.

Authors:  S Taylor
Journal:  Equine Vet Educ       Date:  2015-01-14       Impact factor: 1.063

7.  Osteoarticular Infection in Three Young Thoroughbred Horses Caused by a Novel Gram Negative Cocco-Bacillus.

Authors:  Bernard J Hudson; Catherine Chicken; Anna Blishen; Kristen H Todhunter; Angela P Begg; Leonie Chan; Thomas Karagiannis; Benjamin Raymond; Daniel Bogema; Angus R Adkins; Christopher B O'Sullivan; Brendon A O'Rourke; Piklu Roy Chowdhury; Steven P Djordjevic; Ian G Charles; Andrew Edgar; Katerina Mitsakos
Journal:  Case Rep Vet Med       Date:  2020-01-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.